MAY 26, 2020 7:30 AM PDT

The Hunt for Rare Immune Cells, to InfinityFlow and Beyond

WRITTEN BY: Tara Fernandez

 

The immune landscape is staggeringly complex, with a myriad of genetically and functionally distinct immune cell subpopulations. Researchers have developed a new tool called InfinityFlow to help them classify the identities of these cell subsets with greater precision using artificial intelligence.

White blood cells account for just 1 percent of all blood cells, but form a critical frontline against viruses, bacteria, parasites and other foreign invaders. Produced in the bone marrow, this heterogeneous mix of cell subtypes include monocytes, neutrophils, basophils, and eosinophils — each with their own highly specialized biology and role. 

Immunophenotyping, the protocol used for identifying whilte blood cells, uses a standard “cluster of differentiation” (CD) nomenclature based on the presence of specific cell surface markers. For instance, T-lymphocytes are also known as CD4 cells, and can be distinguished from other white blood cells based on the expression of a CD4 receptor on their cell surface. With research advances, this CD marker library is expanding and immunologists are challenged with accurately assigning markers to immune cell subtypes that may bear only subtle differences in function and anatomical location.

Florent Ginhoux and his team from the Singapore Immunology Network (SIgN) have published a study in Immunology, describing a new method driven by artificial intelligence that characterizes immune cells with unprecedented accuracy based on a panel of 332 markers.

InfinityFlow has revealed the presence of rare immune cell subsets with important implications in autoimmune disease. The CD14 marker was previously thought to be unique to monocytes. However, InfinityFlow analysis has revealed that a tiny fraction of CD14-positive cells are not monocytes at all, but instead dendritic cells, tree-shaped cells known to promote inflammation.

These newly defined dendritic cells were found to contribute to the onset and progression of systemic lupus erythematosus, an autoimmune disease exacerbated by the pro-inflammatory molecules that dendritic cells secrete. InfinityFlow could potentially revolutionize research and drug development for diseases such as cancer, by more precisely profiling immune cells.

“From a clinical perspective, we may get to a point where we can pinpoint which immune cell is the ‘bad guy’ and develop drugs to kill or remove it,” said Ginhoux.

 

 

Sources: A*Star Research, Immunity.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 12, 2020
Immunology
Disabling Genes in Immune Cells Prevents Obesity
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 08, 2020
Immunology
Vaccine Prevents Virally-induced Type 1 Diabetes
MAY 08, 2020
Vaccine Prevents Virally-induced Type 1 Diabetes
Scientists aren’t exactly sure what causes type 1 diabetes, although genetics and environmental factors are presum ...
JUL 08, 2020
Health & Medicine
The Myths About CBD and Coronavirus
JUL 08, 2020
The Myths About CBD and Coronavirus
Research collected over the last 20 years suggests that cannabidiol – the primary cannabinoid in CBD oil – h ...
JUL 07, 2020
Coronavirus
No Evidence Showing Asthma Increases Severity of COVID-19
JUL 07, 2020
No Evidence Showing Asthma Increases Severity of COVID-19
Scientists have been scrambling to learn as much as possible about the novel coronavirus, which causes the disease COVID ...
JUL 30, 2020
Genetics & Genomics
How Are DNA Testing Companies Helping the Fight Against COVID?
JUL 30, 2020
How Are DNA Testing Companies Helping the Fight Against COVID?
One of the most puzzling characteristics of coronavirus is how some people develop severe symptoms and die from the dise ...
SEP 13, 2020
Drug Discovery & Development
Scientists Find Way to Reduce Inflammation from Vaccines
SEP 13, 2020
Scientists Find Way to Reduce Inflammation from Vaccines
Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a ...
Loading Comments...